子宫剖宫产瘢痕妊娠的治疗分析  

Treatment Analysis of Cesarean Scar Pregnancy

作　　者：李靓[1] 刘永莹[1] 张晓萍[1] 

机构地区：[1]安徽阜阳市人民医院妇产科,236000

出　　处：《中华全科医学》2008年第9期919-920,共2页Chinese Journal of General Practice

摘　　要：目的探讨子宫剖宫产疤痕妊娠的药物治疗对此类患者的预后和转归的不同和可行性。方法收集2006年10月-2008年1月我院妇科收治的8例子宫剖宫产瘢痕妊娠的患者,其中有6例进行了药物治疗,有1例误诊为过期流产导致治疗延误,有1例确诊后予手术挖出病灶保留子宫失败最后切宫。结果进行药物治疗的子宫剖宫产瘢痕妊娠6例患者均保留住子宫清除了妊娠,另2例未予药物治疗的患者均未能保留住子宫做了切除手术。结论对确诊的子宫剖宫产瘢痕妊娠的患者进行药物治疗,对保留患者的子宫功能、提高生活质量有着极其重要的作用。Objective To observe the difference of prognosis and outcome of caesarean scar pregnancy after treatment with mifepristone and its feasibility. Methods 8 cases of caesarean scar pregnancy were selected,6 cases were treatment with mife- pristone, no treatment in other 2 cases. Results Embryo tissue was eliminated and uteruses were reserved in 6 cases of caesarean scar pregnancy who were treated with mifepristone,but 2 cases with no medication underwent hysterectomy. Conclusions Treat- ment with mifepristone is vital to retain uterine function for those patients diagnosed as caesarean scar pregnancy.

关 键 词：剖宫产疤痕妊娠 药物治疗 

分 类 号：R714.22[医药卫生—妇产科学]